PE97199A1 - Composiciones solubilizadas de sertralina - Google Patents

Composiciones solubilizadas de sertralina

Info

Publication number
PE97199A1
PE97199A1 PE1998000573A PE00057398A PE97199A1 PE 97199 A1 PE97199 A1 PE 97199A1 PE 1998000573 A PE1998000573 A PE 1998000573A PE 00057398 A PE00057398 A PE 00057398A PE 97199 A1 PE97199 A1 PE 97199A1
Authority
PE
Peru
Prior art keywords
esters
sterby
soltrilized
sertralina
compositions
Prior art date
Application number
PE1998000573A
Other languages
English (en)
Spanish (es)
Inventor
Ravi Mysore Shanker
Scott Max Herbig
Dwayne Thomas Friesen
James Blair West
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE97199(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE97199A1 publication Critical patent/PE97199A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PE1998000573A 1997-07-01 1998-06-26 Composiciones solubilizadas de sertralina PE97199A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
PE97199A1 true PE97199A1 (es) 1999-10-05

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000573A PE97199A1 (es) 1997-07-01 1998-06-26 Composiciones solubilizadas de sertralina

Country Status (34)

Country Link
EP (1) EP0999829A1 (tr)
JP (1) JP2000514100A (tr)
KR (1) KR100366373B1 (tr)
CN (1) CN1261794A (tr)
AP (1) AP1192A (tr)
AR (3) AR015917A1 (tr)
AU (1) AU742535B2 (tr)
BG (1) BG103918A (tr)
BR (1) BR9810739A (tr)
CA (1) CA2290974C (tr)
CO (1) CO4940495A1 (tr)
DZ (1) DZ2548A1 (tr)
EA (1) EA002481B1 (tr)
HN (1) HN1998000102A (tr)
HR (1) HRP980377A2 (tr)
HU (1) HUP0002236A3 (tr)
ID (1) ID23429A (tr)
IL (1) IL133076A (tr)
IS (1) IS5260A (tr)
MA (1) MA24587A1 (tr)
NO (1) NO996520L (tr)
OA (1) OA11243A (tr)
PA (1) PA8454301A1 (tr)
PE (1) PE97199A1 (tr)
PL (1) PL337804A1 (tr)
SK (1) SK181099A3 (tr)
TN (1) TNSN98124A1 (tr)
TR (1) TR199903297T2 (tr)
TW (1) TW550087B (tr)
UA (1) UA67741C2 (tr)
UY (1) UY25071A1 (tr)
WO (1) WO1999001120A1 (tr)
YU (1) YU68299A (tr)
ZA (1) ZA985708B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712222A3 (en) 1999-12-23 2012-06-20 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DE69004529T2 (de) * 1989-08-30 1994-02-24 Pfizer Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
EA199900962A1 (ru) 2000-08-28
YU68299A (sh) 2002-06-19
AR015917A1 (es) 2001-05-30
OA11243A (en) 2003-07-24
HUP0002236A2 (hu) 2003-08-28
SK181099A3 (en) 2000-07-11
TW550087B (en) 2003-09-01
CA2290974A1 (en) 1999-01-14
AP9801280A0 (en) 1998-06-30
AU7544898A (en) 1999-01-25
BG103918A (en) 2000-07-31
CA2290974C (en) 2004-04-27
CN1261794A (zh) 2000-08-02
TR199903297T2 (tr) 2000-07-21
CO4940495A1 (es) 2000-07-24
KR20010013365A (ko) 2001-02-26
AU742535B2 (en) 2002-01-03
NO996520D0 (no) 1999-12-28
IL133076A (en) 2003-12-10
DZ2548A1 (fr) 2003-02-08
HRP980377A2 (en) 1999-04-30
AP1192A (en) 2003-07-23
EP0999829A1 (en) 2000-05-17
KR100366373B1 (ko) 2003-01-14
UY25071A1 (es) 2000-12-29
PL337804A1 (en) 2000-09-11
ID23429A (id) 2000-04-20
IL133076A0 (en) 2001-03-19
HUP0002236A3 (en) 2003-12-29
UA67741C2 (uk) 2004-07-15
AR040279A2 (es) 2005-03-23
MA24587A1 (fr) 1998-12-31
WO1999001120A1 (en) 1999-01-14
PA8454301A1 (es) 2000-09-29
HN1998000102A (es) 1999-01-08
JP2000514100A (ja) 2000-10-24
NO996520L (no) 2000-02-29
IS5260A (is) 1999-11-19
TNSN98124A1 (fr) 2005-03-15
AR040280A2 (es) 2005-03-23
BR9810739A (pt) 2000-09-12
EA002481B1 (ru) 2002-06-27
ZA985708B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
ES2529167T3 (es) Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares
ES2118677T1 (es) Una composicion que comprende un agente activo disuelto en un vehiculo vitrificante y un procedimiento para su preparacion.
ES2151464T3 (es) Preparacion para aplicacion externa que comprende tranilast y procedimiento para producirla.
ES2145557T3 (es) Composiciones de ablandamiento del agua y composiciones detergentes.
AR012531A1 (es) Composicion para cuidado personal, composicion para repasador y metodo para minimizar o reducir la comezon o quemado de la piel a causa de composicionespara cuidado personal que contienen acido.
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
UY27320A1 (es) Nuevas composiciones farmacéuticas
CO5640073A2 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
DE60328705D1 (de) Eine säure und/oder alkohol enthaltendes wasserstoffperoxid-desinfektionsmittel
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
BR9713866A (pt) Composição farmacéutica
AR015884A1 (es) Una composicion cosmetica para su uso en aplicaciones para el cuidado personal, que comprende un portador y una biguanida polimerica, uso de la misma y uso de una biguanida polimerica.
PT1124535E (pt) Sistema conservante para composicoes farmaceuticas topicamente administraveis contendo um sabao de acido gordo/amino acido
CO5031299A1 (es) Composiciones antitranspirantes
AR018357A1 (es) Acido petroselinico en una composicion y en un metodo para reducir o eliminar la irritacion o la picazon de la piel inducida por los alfa-hidroxiacidos
AR056268A1 (es) Tabletas que comprenden una sustancia biologicamente activa y un excipiente
PE97199A1 (es) Composiciones solubilizadas de sertralina
AR003893A1 (es) Composicion cosmetica transparente en barra con 2-metil-1,3-propanodiol.
BRPI0407652A (pt) método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
ES2089824T3 (es) Pasta dentifrica poco filamentosa.
ES2177677T3 (es) Soluciones estables de 2-cloro-2`desoxiadenosina.
AR010716A1 (es) Formulacion para tabletas efervecentes desinfectantes y metodo para formar una solucion desinfectante
ES2143481T3 (es) Comprimido de valproato de sodio de liberacion lenta.
MY143793A (en) Non-tabletted, chewable, individually dosed administration forms

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed